Valneva announces extension of existing loan agreement

Up to an additional $100 million made available in two tranches saint - herblain ( france ), august 1 7 , 202 3 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced an agreement to increase the principal amount of its existing $100 million senior secured debt financing agreement with funds managed by leading u.s. healthcare investment firms deerfield management company and orbimed. the add-on loan facility provides valneva with immediate access to $50 million, with an additional $50 million available at the company's discretion until december 31, 2023.
VALN Ratings Summary
VALN Quant Ranking